We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Nucleic Acid Technology Licensed to Bayer

By HospiMedica staff writers
Posted on 22 Oct 2000
EraGen Biosciences (Alachua, FL, USA), a functional genomics company, has licensed its AEGIS (an expanded genetic information system) synthetic DNA base pair technology to Bayer Diagnostics (Tarrytown, NY, USA). More...
AEGIS permits the detection and manipulation of DNA samples with greater specificity than other DNA analysis methods.

Bayer will utilize AEGIS in its branched DNA (bDNA) technology for nucleic acid testing (NAT), including its test for HIV (HIV-1 RNA 3.0 assay). This test, which uses bDNA technology to measure viral load levels, is designed to assist doctors in monitoring HIV-infected patients.

"Our R&D group has demonstrated that AEGIS base pairs yield improvements across a broad spectrum of DNA assay technologies, including enzyme-based amplification and detection methods,” said Dr. Gideon Shapiro, CEO of EraGen Biosciences. EraGen licenses its bioinformatics, nucleic acid, and genotyping technologies for clinical diagnostic and life science research applications.



Related Links:
Bayer Diagnostics

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.